PURPURA HENOCH SCHONLEIN

ARI MELIYANTI, dr. Sumadiono, SpAK.; dr. Wahyu Damayanti, SpAK

DAFTAR PUSTAKA

1. Matondang, C.S., Roma, J. Purpura Henoch Schonlein. Dalam Akib, A., Munasir, Z.,
penyunting. Alergi dan Imunologi Anak. edisi ke-2. Jakarta: BP IDAI; 2008.
2. Saulsbury FT. Clinical update: Henoch-Schonlein purpura. Lancet 2007; 369(3): 976–
978.
3. Calvino, M.C., Llorca, J., Garcia-Porrua, C., Fernandez-Iglesias, J.L., Rodriguez-
Ledo, P., Gonzalez-Gay, M.A. Henoch-Schonlein purpura in children from
Northwestern Spain: a 20-year epidemiologic and clinical study. Medicine 2001; 80:
279–290.
4. Brogan P, Eleftheriou D, Dillon M. Small vessel vasculitis. Pediatr Nephrol
2010;25:1025-35
5. White JHR, Yoshikawa N, Feehally J. Ig A Nephropaty and Henoch-Schonlein.
Dalam Barrat
TM, Avner ED, Harmon WE, penyunting. Pediatric Nephrology. Edisi 4.
Philadelphia:LippincottWilliams and Wilkins; 1999.
6. Cameron, J.S., Chandler, C., Ogy, C.S., White, R.H.R. Longterm stability of
remission in nephrotic syndrome after treatment with cyclophosphamide. Br Med J,
2007; 4: 7(7).
7. Mills, J.A., Michel, B.A., Bloch, D.A., Calabrese, L.H., Hunder, G.G., Arend, W.P.,
et al. The American College of Rheumatology 1990 criteria for the clasification of
Henoch-Schonlein purpura. Arthritis Rheum 1990; 33: 1114-21.
8. Ozen, S., Pistorio, A., Iusan, M., Bakkaloglu, A., Herlin, T., Brik, R., Uziel, S.,
Stabile, A., et al. PaediatricRheumatology International Trials Organisation
(PRINTO) (2009) The EULAR/PRINTO/PREScriteria for Henoch-Schönlein
purpura. Ann Rheum Dis 2009; 68(Suppl 3): 712.
9. Ozen, S., Ruperto, N., Dillon, M.J., Bagga, A., Barron, K., Davin, J., et al.
EULAR/PReS endorsed consensus criteria for the classification of childhood
vasculitides. Ann Rheum Dis 2006; 65: 936-41.
10. Reamy, B., Williams, P.M. Henoch-Schonlein Purpura. Am Fam Physician 2009;
80(7): 697-704.
11. Masuda, M., Nakanishi, K., Yoshizawa, N., Iijima, K. Group A streptococcal antigen
in the glomeruli of children with Henoch-Schönlein nephritis. Am J Kidney Dis 2003;
41(2): 366-370.
12. Jennette, J.C., Falk, R.J. Small-vessel vasculitis. N Engl J Med. 1997; 337(21): 1512-
1523.
13. Sohagia, A.B., Gunturu, S.G., Tong, T.R., Hertan, H.I. Henoch Schonlein Purpura a
case report and review of the literature. Gastroenterol Res Pract 2010: 1-7
14. Narchi, H. Risk of long term renal impairment and duration of follow up
recommended for Henoch-Schonlein purpura with normal or minimal urinary
findings: a systematic review. Arch Dis Child. Sep 2005; 90(9): 916-20.
15. Chen, K.R., Carlson, J.A. Clinical approach to cutaneous vasculitis, American Journal
of Clinical Dermatology 2008; 9(2): 71–92.
16. Ebert, E.C., Gastrointestinal manifestations of Henoch-Sch¨onlein purpura, Digestive
Diseases and Sciences 2008; 53(8): . 2011–2019.
17. Garcia-Porrua, C., Gonzalez-Louzao, C., Llorca, J., et al.,“Predictive factors for renal
sequelae in adults with Henoch-Sch¨onlein purpura,” Journal of Rheumatology 2001;
28(5): 1019–1024.

58
 PURPURA HENOCH SCHONLEIN
ARI MELIYANTI, dr. Sumadiono, SpAK.; dr. Wahyu Damayanti, SpAK
Universitas Gadjah Mada, 2017 | Diunduh dari http://etd.repository.ugm.ac.id/

18. Fretzayas, A., Sionti, I., Moustaki, M., Nicolaidou, P. Clinical impact of altered
immunoglobulin levels in Henoch-Sch¨onlein purpura, Pediatrics International 2009;
51(3): 381–384.
19. Lippl, F., Huber, W., Werner, M., Nekarda, H., Berger, H.,Weigert, N. Life-
threatening gastrointestinal bleeding due to a jejunal lesion of Henoch-Schönlein
purpura. Endoscopy 2001; 33: 811-3.
20. Katz, S., Borst, M., Seekri, I., Grosfeld, J.L. Surgical evaluation of Henoch -
Schönlein purpura- experience with 110 children. Arch Surg 1991; 126: 849-54.
21. Tomomasa, T., Hsu, J.Y., Itoh, .K, Kuroume, T. Endoscopic findings in pediatric
patients with Henoch-Schönlein purpuraand gastrointestinal symptoms. J Pediatr
Gastroenterol Nutr 1987; 6: 725-9.
22. Albar H. Nefritis Henoch-Schonlein. Dalam Noer, M.S., Alatas, H., Tambunan, T.,
ardede, S.,Sekarwana, N., et al, penyunting. Kompendium Nefrologi Anak. Jakarta:
BP IDAI 2011.
23. Lau, K.K., Suzuki, H., Novak, J., Wyatt, R. J. Pathogenesis of Henoch-Schonlein
purpura nephritis.Pediatr Nephrol 2010; 25: 19-26.
24. Stuart, F.A., Segal, T.Y., Keady, S. Adverse Psychological Effects of Corticosteroids
in Children and Adolescents. Arch Dis Child 2005; 90: 500-506.
25. Rieder, M.J. The Child with Multiple Short Courses of Steroid Therapy. Paediatr
Child Health 2003; 8(4): 226.
26. Davin, J.C. Henoch Schonlein Purpura Nephritis: Pathophysiology, Treatment, and
Future Strategy. Clin J Am Soc Nephrol 2011; 6: 679-689.
27. Adam, J.R. Henoch Schonlein Purpura. Pediatrics in Review 2014; 35(10): 447-9.
28. Goldstein,A., White, R., Akuse, R., Chantler,C. Long-term Follow-up of Childhood
Henoch-Schonlein Nephritis. Lancet 1992; 339: 280–282.
29. Jauhola, O. Henoch Schonlein Purpura in Children. ACTA Universitatis Ouluensis:
Juvenes Print 2012.
30. Trnka, P. Henoch Schonlein Purpura in Children. Journal of Paediatrics and Child
Health 2013; 49: 995-1003.
31. Chen, O., Zhu, X.B., ren, P., Wang, Y.B., Sun, R.P., Wei, D.E. Henoch Schonlein
Purpura in Children: Clinical analysis of 120 Cases. African Health Science 2013;
13(1): 94-99.
32. Zaffanello, M. Henoch Schonlein Purpura Nefritis in Childhood. an Update on
Glomerulopathies Clinical and Treatment aspects . Italia: Intech 2011.
33. Alfredo C.S., Nunes, N.A., Len, C.A., Barbosa, C.M.P., Terreri, M.T.R.A., Hilario,
M.O.E. Henoch-Schönlein purpura: recurrence and chronicity. Jornal de Pediatria
2007; 83(2): 177-180.
34. Weiss, P.F. Pediatric Vasculitis. Pediatr Clin North Am 2012; 59(2): 407-423.
35. Aljebab, F., Choonara, I., Conroy, S. Systematic Review of the Toxicity of Short-
Course Oral Corticosteroids in Children. Arch Dis Child 2016; 101: 365-370.
36. Aljebab, F., Choonara, I., Conroy, S. Systematic Review of the Toxicity of Long
Course Oral Corticosteroids in Children. PLOS one 2016; 12(1): 1-18.
37. Fotis, L., Tuttle IV, P.V., Baszis, K. W., Pepmueller, P.H., Moore, T. L., White, A. J.
Azathioprine Therapy for steroid resistant Henoch Schonlein Purpura: a report of 6
cases. Pediatric Rheumatology 2016; 14(37): 1-7.
38. Weiss, P. F., Feinstein, J. A., Luan, X., Burnham, J.M., Feudtner, C. Effect of
Corticosteroid on Henoch Schonlein Purpura: A Systematic Review. Pediatrics 2007;
120(5): 1079-1087.
39. Chen, S. Y., Kong, M.S., Gastrointestinal Manifestations and Complications of
Henoch Schonlein Purpura. Chang Gung Med J 2004; 27(3) : 175-81.

59
 PURPURA HENOCH SCHONLEIN
ARI MELIYANTI, dr. Sumadiono, SpAK.; dr. Wahyu Damayanti, SpAK
Universitas Gadjah Mada, 2017 | Diunduh dari http://etd.repository.ugm.ac.id/

40. Bluman, J., Goldman, R.D. Henoch Schonlein Purpura in Children Limited Benefit of
Corticosteroids. Canadian Family Physician 2014; 60: 1007-1010
41. Chan, H., Tang, Y.L., Hang Lv, X., Zhang, G.F., Wang, M., Yang, H.P., Li, Q. Risk
Factors Associated with Renal Involvement in Childhood Henoch Schonlein Purpura:
A Meta-Analysis. PLOS one 2016; 11(11): 1-21.
42. Kawasaki, Y. The Pathogenesis and Treatment of Pediatric Henoch Schonlein
Purpura Nefritis. Clin Exp Nephrol 2011; 15: 648-657.
43. Pasha, A.B., Zhou, G.P. Recent Advances in the Treatment of Henoch Schonlein
Purpura. Science Letters 2017; 5(2): 131-137.
44. Calvo-Rio, V., Hernandez, J.L., Sanjuan, F.O., Loricera, J., Fontana, N.P., Gonzalez-
Vela, M.C., et al. Relapses in Patients with Henoch Schonlein Purpura. Medicine
2016; 95(28): 1-8.
45. Wardhana, A.W., Satria, C.D., Sunartini. Faktor Prediktor Nefritis pada Anak dengan
Purpura Henoch Schonlein. Sari Pediatri 2016; 18(3): 2009-13.
46. Hahn, D., Hodson, E.M., Willis, N.S., Craig, J.C. Interventions for Preventing and
Treating Kidney Disease in Henoch Schonlein Purpura(HSP) (Review). Cochrane
Database of Systematic Reviews 2015;8: 1-52.
47. Wang, X., Zhu, Y., Gao, L.,Wei, S., Zhen, Y., Ma, Q. Henoch-Schönlein purpura with
joint involvement: Analysis of 71 cases. Pediatric Rheumatology 2016; 14(20) : 1-8.

60